A systematic mapping of the genomic and proteomic variation associated with monogenic diabetes

Kuznetsova, K.; Vasicek, J.; Skiadopoulou, D.; Molnes, J.; Udler, M.; Johansson, S.; Njolstad, P. R.; Manning, A. K.; Vaudel, M.

doi:10.1101/2023.01.19.524722

bioRxiv · 10.1101/2023.01.19.524722

A systematic mapping of the genomic and proteomic variation associated with monogenic diabetes

Kuznetsova, K.·Vasicek, J.·Skiadopoulou, D.·Molnes, J.·Udler, M.·Johansson, S.·Njolstad, P. R.·Manning, A. K.·Vaudel, M.

View original source ↗Export metadata ↓

Abstract

AimsMonogenic diabetes is characterized as a group of diseases caused by rare variants in single genes. Multiple genes have been described to be responsible for monogenic diabetes, but the information on the variants is not unified among different resources. In this work, we aimed to develop an automated pipeline that collects all the genetic variants associated with monogenic diabetes from different resources, unify the data and translate the genetic sequences to the proteins. MethodsThe pipeline developed in this work is written in Python with the use of Jupyter notebook. It consists of 6 modules that can be implemented separately. The translation step is performed using the ProVar tool also written in Python. All the code along with the intermediate and final results is available for public access and reuse. ResultsThe resulting database had 2701 genomic variants in total and was divided into two levels: the variants reported to have an association with monogenic diabetes and the variants that have evidence of pathogenicity. Of them, 2565 variants were found in the ClinVar database and the rest 136 were found in the literature showing that the overlap between resources is not absolute. ConclusionsWe have developed an automated pipeline for collecting and harmonizing data on genetic variants associated with monogenic diabetes. Furthermore, we have translated variant genetic sequences into protein sequences accounting for all protein isoforms and their variants. This allows researchers to consolidate information on variant genes and proteins associated with monogenic diabetes and facilitates their study using proteomics or structural biology. Our open and flexible implementation using Jupyter notebooks enables tailoring and modifying the pipeline and its application to other rare diseases. Research in contextO_LIMonogenic diabetes is a group of Mendelian diseases with an autosomal-dominant pattern of inheritance. C_LIO_LIMonogenic diabetes is mainly caused by rare genetic variants that are usually evaluated manually. C_LIO_LIThe data on the variants are stored in several resources and are not unified in terms of the genomic coordinates, alleles, and variant annotation. C_LIO_LIWhat can be done for the systematic evaluation of the variants and their protein consequences? C_LIO_LIIn this work, we have created an automated Jupyter notebook-based pipeline for the collection and unification of the variants associated with monogenic diabetes. C_LIO_LIThe database of the genetic variants was created and translated to all possible variant protein sequences. C_LIO_LIThese results will be used for the analysis of proteomics data and protein structure modeling. C_LI

Explore related subjects

bioinformatics Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Kuznetsova, K., Vasicek, J., Skiadopoulou, D., Molnes, J., Udler, M., Johansson, S., Njolstad, P. R., Manning, A. K., Vaudel, M.. 2023-01-20. A systematic mapping of the genomic and proteomic variation associated with monogenic diabetes. https://doi.org/10.1101/2023.01.19.524722

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Uncovering Viral Signals Across Cell Populations in Colorectal Cancer

Viral sequences have been detected in colorectal cancer, but their cellular and anatomical distribution remains poorly resolved. We aimed to establish a cell-type-resolved map of viral reference-associated RNA signals across colorectal cancer, tumour-adjacent normal tissue, and healthy colon. We repurposed human-unmapped reads from single-cell RNA sequencing libraries generated in ten publicly available studies. We retained cell-barcode and unique molecular identifier information, removed duplicate molecules, and aligned reads to a curated human-associated viral reference using three aligners. Viral signals were analysed across cell types, tissue conditions, and colorectal segments. We used participant-grouped repeated cross-validation to evaluate tissue-condition classification and screened an independent paired colorectal cancer proteomics cohort for compatible peptide matches. The study included 547 libraries from 112 participants, including 49 with matched colorectal cancer and tumour-adjacent normal samples, and approximately 415,000 cells spanning ten major cell populations. Viral reference-associated RNA signals differed across epithelial, immune, stromal, and vascular compartments, tissue conditions, and anatomical regions of the colon. Of 318 independent healthy-reference viral-load comparisons, seven involving six virus-cell-type groups remained significant after Benjamini-Hochberg correction, including plasma-cell HHV-7 and HHV-6B and mast-cell HCV-2. Cell-type-resolved viral features distinguished colorectal cancer, tumour-adjacent normal tissue, and healthy colon in participant-grouped validation; random forest achieved a macro-AUC of 0.957 (SD 0.028), with HERV-K113 as the leading quantitative feature. An independent proteomic screen identified peptide matches compatible with 20 candidate viral groups. We established a cell-type-resolved map of viral reference-associated RNA signals across colorectal tissue conditions and anatomical regions. By identifying candidate viral signals in epithelial and immune compartments, this map provides a basis for investigating virus-host pathways involved in tumour biology, immune regulation, and antigen-presentation states, and could help prioritise future combination strategies pairing virus-directed or virus-mimetic approaches with standard treatment or immune checkpoint blockade.

bioinformatics↗

bioRxiv2026

Statistical significance testing for spatial domain detection in spatial transcriptomics

In spatial transcriptomics, domain-detection methods group platform-specific spatial measurement units--cells, bins or multicellular spots--into spatial domains for comparing molecular programs, cellular composition and interactions among tissue regions. However, the number of candidate domains detected in the same tissue can vary with user-specified parameters or model-selection criteria. Whether candidate domains should be merged can be framed as a test of a single-domain null hypothesis, under which each gene has constant mean expression across all spatial units in the combined region. However, testing candidate domains on the same gene-expression data used to detect them may induce post-selection bias and yield anti-conservative p-values, increasing the risk of oversegmentation. To address these challenges, we introduce SigDoTS (statistical Significance testing for Domain deTection in Spatial transcriptomics), a hypothesis-testing framework for spatial domain detection. SigDoTS uses hierarchical testing to determine which candidate domains to retain or merge, with adjustment for family-wise error control. It accounts for gene-gene covariance and spatial dependence and computes p-values by rerunning the upstream domain-detection pipeline on datasets simulated under the fitted single-domain null. In simulations, SigDoTS controlled the type I error rate at the root node under the single-domain null and improved recovery of the true spatial domains when multiple domains were present. In human dorsolateral prefrontal cortex, SigDoTS retained superficial and deep Layer 6 domains but merged Layer 3 candidate domains across different initial numbers of candidate domains. In ovarian and colorectal cancers, SigDoTS retained epithelial domains with different gene-expression programs and local immune environments, together with immune, stromal and vascular domains.

bioinformatics↗

bioRxiv2026

ASD Neuro Agentic (ANA): An Agentic Framework for Feature Discovery and Cross Site Generalization in Autism fMRI Classification

Classifiers of autism spectrum disorder (ASD) from resting state functional MRI rarely generalize across sites, and many reported accuracies are inflated by data leakage.We show that an agentic artificial intelligence framework, ASD Neuro Agentic (ANA), whose language model agents propose features from the literature and researcher input while fixed tools perform every calculation, can search auditably for site independent classifiers while controlling the leakage. In 1,028 participants from 17 ABIDE I centers, ANA tested 71 pipelines and selected a ComBat harmonized ensemble of tangent space connectivity models from six parcellations and 98 public connectivity derivatives. In leave one center out testing, the ensemble reached an area under the curve of 0.814 (95% CI, 0.773 to 0.841), outperforming ASD DiagNet and ASD SAENet. Predictive connectivity was mainly reduced in ASD. Agentic AI offers a systematic and efficient approach to exploring, evaluating, and identifying pipelines as model selection grows complex.

bioinformatics↗